Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Rheumatoid Arthritis

  Free Subscription


04.02.2019

2 Ann Rheum Dis
1 Arthritis Res Ther
1 BMJ
2 Curr Opin Rheumatol
1 Eur J Immunol
1 J Arthroplasty
2 PLoS One
1 Z Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. PAWAR A, Desai RJ, Solomon DH, Santiago Ortiz AJ, et al
    Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.
    Ann Rheum Dis. 2019 Jan 24. pii: annrheumdis-2018-214367.
    PubMed     Text format     Abstract available

  2. FISHER BA, Everett CC, Rout J, O'Dwyer JL, et al
    Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.
    Ann Rheum Dis. 2018;77:412-416.
    PubMed     Text format     Abstract available


    Arthritis Res Ther

  3. VOMERO M, Manganelli V, Barbati C, Colasanti T, et al
    Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs.
    Arthritis Res Ther. 2019;21:39.
    PubMed     Text format     Abstract available


    BMJ

  4. GOTTENBERG JE, Morel J, Perrodeau E, Bardin T, et al
    Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study.
    BMJ. 2019;364:l67.
    PubMed     Text format     Abstract available


    Curr Opin Rheumatol

  5. PONTARINI E, Lucchesi D, Bombardieri M
    Current views on the pathogenesis of Sjogren's syndrome.
    Curr Opin Rheumatol. 2018;30:215-221.
    PubMed     Text format     Abstract available

  6. HAMMAKER D, Firestein GS
    Epigenetics of inflammatory arthritis.
    Curr Opin Rheumatol. 2018;30:188-196.
    PubMed     Text format     Abstract available


    Eur J Immunol

  7. LLOYD KA, Steen J, Amara K, Titcombe PJ, et al
    Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection.
    Eur J Immunol. 2018;48:1030-1045.
    PubMed     Text format     Abstract available


    J Arthroplasty

  8. MIURA M, Hagiwara S, Nakamura J, Wako Y, et al
    Interobserver and Intraobserver Reliability of Computed Tomography-Based Three-Dimensional Preoperative Planning for Primary Total Knee Arthroplasty.
    J Arthroplasty. 2018;33:1572-1578.
    PubMed     Text format     Abstract available


    PLoS One

  9. TOKAI N, Yoshida S, Kotani T, Yoshikawa A, et al
    Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
    PLoS One. 2019;14:e0211750.
    PubMed     Text format     Abstract available

  10. MCKELVEY KJ, Millier MJ, Doyle TC, Stamp LK, et al
    Co-expression of CD21L and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation.
    PLoS One. 2018;13:e0202135.
    PubMed     Text format     Abstract available


    Z Rheumatol

  11. GAUBITZ M, Lippe R, Gottl KH, Luthke K, et al
    [Etanercept in routine German clinical practice to treat rheumatoid arthritis patients : A one-year observational study on effectiveness, safety and health economics].
    Z Rheumatol. 2019 Jan 25. pii: 10.1007/s00393-018-0536.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: